"From a Whisper to a Roar" is the story of St. Louis native Mellve Shahid who has shown that even in the face of adversity, goodness can prevail. Shahid survived prostate cancer and turned his battle ...

Living with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma, is about more than treatment cycles and scans. It’s about how you live in the midst of it — equipping ...

All three CAR T-Cell Therapies that have FDA approval for a relapse of diffuse large B-cell lymphoma—axi-cel, liso-cel, and tisa-cel—share a common goal: reprogramming your own immune system to ...

Isabella Strahan, 21, learned that her beauty isn’t defined by her hair after battling medulloblastoma, an aggressive brain cancer. Following surgery, radiation, and chemotherapy, she now embraces ...

2. From Shock to Support: How Caregivers Can Help After a Lymphoma Diagnosis Dr. Lauren C. Pinter-Brown UC Irvine Comprehensive Cancer Center Assuming the role of a caregiver when someone you love is ...

Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment. Here, Dr. Edward Nelson helps outline the key considerations for ...

Dr. Rodrigo C. Leão Edelmuth is a Board Certified Digestive Surgeon at Einstein Hospital Israelita in Sao Paulo, Brazil. Einstein is internationally acclaimed, ranked 22nd best hospital in the world ...

For many many women diagnosed with early-stage, hormone receptor–positive (HR-positive), HER2-negative breast cancer, treatment after surgery usually includes hormone-blocking pills (called endocrine ...

James Van Der Beek is urging men to get screened for colorectal cancer after his own diagnosis two years ago, using his platform to highlight how simple it can be to discover the disease early on, ...

CAR T-Cell Therapy has revolutionized treatment for relapsed or refractory diffuse large B-cell lymphoma, offering new hope—but it also comes with serious risks, including a potentially ...

Eight years after surviving neck and throat cancer, two time Academy Award winning actor Michael Douglas, 74, says that dying wasn’t really part of his thought process about his disease. Douglas was ...